Abstract
The pathogenesis of the inflammatory bowel diseases (IBD), which include ulcerative colitis and Crohn’s disease, is still not fully understood. It is likely that proinflammatory cytokine release and derangement of the immune response play a role in the inflammatory processes (1,2), whereas the roles of a wide range of proinflammatory mediators are currently under investigation. In addition, the release of more ephemeral cytotoxic species such as reactive oxygen species or nitric oxide (NO) and other nitrogen species may also be involved in creating epithelial and microvascular injury (3–8). The expression of the inducible calcium-independent isoform of nitric oxide synthase (iNOS) can be considered as a marker of the inflammatory response in the gut. Thus, the quantities of NO produced by iNOS, either by inflammatory cells or the gut tissue, particularly the epithelium, may be involved in both initial cell injury along with oxygen radical such as superoxide, which forms the injurious peroxynitrite, as well as in the subsequent healing of the tissue injury (3–8).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kappeler, A. and Mueller, C. (2000) The role of activated cytotoxic T cells in inflammatory bowel disease. Histol. Histopathol. 15, 167–172.
Papadakis, K. A. and Targan, S. R. (2000). Role of cytokines in the pathogenesis of inflammatory bowel disease. Ann. Rev. Med. 51, 289–298.
Boughton-Smith, N. K., Evans, S. M., Hawkey, C. J., Cole, A. T., Balsitis, M., Whittle B. J. R., et al. (1993) Nitric oxide synthase activity in ulcerative colitis and Crohn’s disease. Lancet 342, 338–340.
Dijkstra, G., Moshage, H., van Dullemen, H. M., de Jager-Krikken, A., Tiebosch, A. T., Kleibeuker, J. H., et al. (1998) Expression of nitric oxide synthases and formation of nitrotyrosine and reactive oxygen species in inflammatory bowel disease. J. Pathol. 186, 416–421.
Singer, I. I., Kawka, D. W, Scott, S., Weidner, J. R., Mumford, R. A., Riehl, T. E., et al. (1996) Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease. Gastroenterology 111, 871–885.
Boughton-Smith, N. K., Evans, S. M., Whittle, B. J. R., and Moncada, S. (1993) Induction of nitric oxide synthase in rat intestine and its association with tissue injury. Agents Actions 38, C125–126.
Whittle, B. J. R. (1997) Nitric oxide-a mediator of inflammation or mucosal defence. Eur. J. Gastroenterol. Hepatol. 9, 1026–1032.
Kubes, P. (2000) Inducible nitric oxide synthase: a little bit of good in all of us. Gut 47, 6–9.
Sartor, R. B. (1997) Review article: How relevant to human inflammatory bowel disease are current animal models of intestinal inflammation? Aliment. Pharmacol. Ther. 11, 89–96.
Morris, G. P., Beck P. L., Herridge, M. S., Depew, W. T., Szewczuk, M. R., and Wallace, J. L. (1989) Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 96, 795–803.
Boughton-Smith, N. K., Wallace, J. L., Morris G. P., and Whittle, B. J. R. (1988) The effect of anti-inflammatory drugs on eicosanoid formation in a chronic model of inflammatory bowel disease in the rat. Br. J. Pharmacol. 94, 65–72
Boughton-Smith, N. K. and Whittle, B. J. R. (1988). Laboratory methods for studying the role of eicosanoids in inflammatory bowel disease. In Advances in Eicosanoid Research-Eicosanoids and the Gastrointestinal Tract (Hiller, K., ed.), MTP, Lancaster, PA, pp. 12–45.
Grisham, M. B., Volkmer, C., Tso, P., and Yamada, T. (1991) Metabolism of trinitrobenzene sulfonic acid by the rat colon produces reactive oxygen species. Gastroenterology 101, 540–547.
Yamada, Y, Marshall, S., Specian, R. D., and Grisham, M. B. (1992) A comparative analysis of two models of colitis in rats. Gastroenterology 102, 524–534.
Torres, M. I., Garcia-Martin, M., Fernandez, M. I., Nieto, N., Gil, A., and Rios, A. (1999) Experimental colitis induced by trinitrobenzenesulfonic acid: an ultrastructural and histochemical study. Dig. Dis. Sci. 44, 2523–2529.
Neurath, M., Fuss, I., and Strober W. (2000) TNBS-colitis. Int. Rev. Immunol. 19, 51–62.
Hoffmann, P., Zeeh, J. M., Lakshmanan, J., Wu, V. S., Procaccino, F., Reinshagen, M., et al. (1997) Increased expression of transforming growth factor alpha precursors in acute experimental colitis in rats. Gut 41, 195–202.
Jacobson, K., McHugh, K., and Collins, S. M. (1997) The mechanism of altered neural function in a rat model of acute colitis. Gastroenterology 112, 156–162.
Miampamba, M. and Sharkey, K. A. (1998) Distribution of calcitonin gene-related peptide, somatostatin, substance P and vasoactive intestinal polypeptide in experimental colitis in rats. Neurogastroenterol. Motil. 10, 315–329.
Stein, J., Ries, J., and Barrett, K. E. (1998) Disruption of intestinal barrier function associated with experimental colitis: possible role of mast cells. Am. J. Physiol. 274, G203–209.
Sans, M., Panes, J., Ardite, E., Elizalde, J. I., Arce, Y., Elena, M., et al. (1999) VCAM-1 and ICAM-1 mediate leukocyte-endothelial cell adhesion in rat experimental colitis. Gastroenterology 116, 874–883.
Ballinger, A., El-Haj, T., Perrett, D., Turvill, J., Obeid, O., Dryden, S., et al. (2000) The role of medial hypothalamic serotonin in the suppression of feeding in a rat model of colitis. Gastroenterology 118, 544–553.
Hoffmann, P., Reinshagen, M., Zeeh, J. M., Lakshmanan, J., Wu, V. S., Goebell, H., et al. (2000) Increased expression of epidermal growth factor-receptor in an experimental model of colitis in rats. Scand. J. Gastroenterol. 35, 1174–1180.
Chang, Q., Soper, B. D., Yacyshyn, B. R., and Tepperman, B. L. (2000) Alterations in protein kinase C isoforms in experimentally-induced colitis in the rat. Inflamm. Res. 49, 27–35.
Lin, C. L., Moniz, C. and Chow, J. W. (2000) Treatment with fluoride or bisphosphonates prevents bone loss associated with colitis in the rat. Calcif. Tissue Int. 67, 373–377.
Ardite, E., Sans, M., Panes, J., Romero, F. J., Pique, J. M., and Fernandez-Checam J. C. (2000) Replenishment of glutathione levels improves mucosal function in experimental acute colitis. Lab. Invest. 80, 735–744.
Sun, F. F., Lai, P. S., Yue, G., Yin, K., Nagele, R. G., Tong, D. M., et al. (2001) Pattern of cytokine and adhesion molecule mRNA in hapten-induced relapsing colon inflammation in the rat. Inflammation 25, 33–45.
Hoffmann, J. C., Peters, K., Henschke, S., Herrmann, B., Pfister, K., Westermann, J., et al. (2001) Role of T lymphocytes in rat 2,4,6-trinitrobenzene sulfonic acid (TNBS) induced colitis: increased mortality after gamma delta T cell depletion and no effect of alpha beta T cell depletion. Gut 48, 489–495.
Sans, M., Salas, A., Soriano, A., Prats, N., Gironella, M., Pizcueta, P., et al. (2001) Differential role of selectins in experimental colitis. Gastroenterology 120, 1162–1172.
Seo, H. G., Takata, I., Nakamura, M., Tatsumi, H., Suzuki, K., Fujii, J., et al. (1995) Induction of nitric oxide synthase and concomitant suppression of superoxide dismutases in experimental colitis in rats. Arch. Biochem. Biophys. 24, 41–47.
Kiss, J., Lamarque, D., Delchier, J. C. and Whittle, B. J. R. (1997) Time-dependent actions of nitric oxide synthase inhibition on colonic inflammation induced by trinitrobenzene sulfonic acid in rats. Eur. J. Pharmacol. 336, 219–224.
Yue G., Lai, P. S., Yin, K., Sun, F. F., Nagel, R. G., Liu, X., et al. (2001) Colon epithelial cell death in 2,4,6-trinitrobenzenesulfonic acid-induced colitis is associated with increased inducible nitric-oxide synthase expression and peroxynitrite production. J. Pharmacol. Exp. Ther. 297, 915–925
Bradley, P. P., Priebat, D. A., Christensen, R. D., and Rothstein, G. (1982) Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J. Invest. Dermatol. 78, 206–209.
McCafferty, D. M., Sharkey, K. A., and Wallace, J. L. (1994) Beneficial effects of local or systemic lidocaine in experimental colitis. Am. J. Physiol. 266, G560–567.
Palmen, M. J., Dijkstra, C. D., van der Ende, M. B., Pena, A. S., and van Rees, E. P. (1995) Anti-CD11b/CD18 antibodies reduce inflammation in acute colitis in rats. Clin. Exp. Immunol. 101, 351–356.
Veljaca, M., Lesch, C. A., Pllana, R., Sanchez, B., Chan, K., and Guglietta, A. (1995) BPC-15 reduces trinitrobenzene sulfonic acid-induced colonic damage in rats. J. Pharmacol. Exp. Ther. 272, 417–422.
Tatsumi, Y. and Lichtenberger, L. M. (1996) Molecular association of trinitrobenzenesulfonic acid and surface phospholipids in the development of colitis in rats. Gastroenterology 110, 780–789.
Yue, G., Sun, F. F., Dunn, C., Yin, K., and Wong, P. Y. (1996) The 21-aminosteroid tirilazad mesylate can ameliorate inflammatory bowel disease in rats. J. Pharmacol. Exp. Ther. 276, 65–70.
Peterson, T. C. and Davey, K. (1997) Effect of acute pentoxifylline treatment in an experimental model of colitis. Aliment. Pharmacol. Ther. 11, 575–580.
Ribbons, K. A., Thompson, J. H., Liu, X., Pennline, K., Clark, D. A., and Miller, M. J. (1997) Anti-inflammatory properties of interleukin-10 administration in hapten-induced colitis. Eur. J. Pharmacol. 323, 245–254.
Miampamba, M., Parr, E. J., McCafferty, D. M., Wallace, J. L., and Sharkey, K. A. (1998) Effect of intracolonic benzalkonium chloride on trinitrobenzene sulfonic acid-induced colitis in the rat. Aliment. Pharmacol. Ther. 12, 219–228.
Eliakim, R., Karmeli, F., Rachmilewitz, D., Cohen, P., and Fich, A. (1998) Effect of chronic nicotine administration on trinitrobenzene sulfonic acid-induced colitis. Eur. J. Gastroentero. Hepatol. 10, 1013–1019.
Zingarelli, B., Cuzzocrea, S., Szabo, C., and Salzman, A. L. (1998) Mercaptoethylguanidine, a combined inhibitor of nitric oxide synthase and peroxynitrite scavenger, reduces trinitrobenzene sulfonic acid-induced colonic damage in rats. J. Pharmacol. Exp. Ther. 287, 1048–1055.
Kim, Y. S., Son, M., Ko, J. I., Cho, H., Yoo, M., Kim, W. B., et al. (1999) Effect of DA-6034, a derivative of flavonoid, on experimental animal models of inflammatory bowel disease. Arch. Pharm. Res. 22, 354–360
Tozaki, H., Fujita, T., Odoriba, T., Terabe, A., Okabe, S., Muranishi, S., et al. (1999) Validation of a pharmacokinetic model of colon-specific drug delivery and the therapeutic effects of chitosan capsules containing 5-aminosalicylic acid on 2,4,6-trinitrobenzenesulfonic acid-induced colitis in rats. J. Pharm. Pharmacol. 51, 1107–1112.
Sykes, A. P., Bhogal, R., Brampton, C., Chander, C., Whelan, C., Parsons, M. E., et al. (1999) The effect of an inhibitor of matrix metalloproteinases on colonic inflammation in a trinitrobenzenesulfonic acid rat model of inflammatory bowel disease. Aliment. Pharmacol. Ther. 13, 1535–1542.
Gulluoglu, B. M., Kurtel, H., Gulluoglu, M. G., Aktan, A. O., Yegen, B. C., Dizdaroglu, F., et al. (1999) Bombesin ameliorates colonic damage in experimental colitis. Dig. Dis. Sci. 44, 1531–1538.
McCafferty, D. M., Smith, C. W., Granger, D. N., and Kubes, P. (1999) Intestinal inflammation in adhesion molecule-deficient mice: an assessment of P-selectin alone and in combination with ICAM-1 or E-selectin. J. Leuko. Biol. 66, 67–74.
Tozaki, H., Fujita, T., Odoriba, T., Terabe, A., Suzuki, T., Tanaka, C., et al. (1999) Colon-specific delivery of R68070, a new thromboxane synthase inhibitor, using chitosan capsules: therapeutic effects against 2,4,6-trinitrobenzene sulfonic acid-induced ulcerative colitis in rats. Life Sci. 64, 1155–1162.
Padol, I., Huang, J. Q., Hogaboam, C. M., and Hunt, R. H. (2000) Therapeutic effects of the endothelin receptor antagonist Ro 48-5695 in the TNBS/DNBS rat model of colitis. Eur. J. Gastroenterol. Hepatol. 12, 257–265.
Peterson, T. C., Cleary, C. E., Shaw, A. M., Malatjalian, D. A., and Veldhuyzen van Zanten, S. J. (2000) Therapeutic role for bismuth compounds in TNBS-induced colitis in the rat. Dig. Dis. Sci. 45, 466–473.
Kennedy, R. J., Hoper, M., Deodhar, K., Kirk, S. J., and Gardiner, K. R. (2000) Probiotic therapy fails to improve gut permeability in a hapten model of colitis. Scand. J. Gastroenterology 35, 1266–1271.
Galvez, J., Garrido, M., Merlos, M., Torres, M. I., and Zarzuelo, A. (2000). Intestinal anti-inflammatory activity of UR-12746, a novel 5-ASA conjugate, on acute and chronic experimental colitis in the rat. Br. J. Pharmacol. 130, 1949–1959.
Girgin, F., Karaoglu, O., Erkus, M., Tuzun, S., Ozutemiz, O., Dincer, C., et al. (2000). Effects of trimetazidine on oxidant/antioxidant status in trinitro-benzenesulfonic acid-induced chronic colitis. J. Toxicol. Environ. Health. A. 59, 641–652.
D’Argenio, G., Grossman, A., Cosenza, V., Valle, N. D., Mazzacca, G. and Bishop, P. D. (2000). Recombinant factor XIII improves established experimental colitis in rats. Dig. Dis. Sci. 45, 987–997.
Reinshagen, M., Rohm, H., Steinkamp, M., Lieb, K., Geerling, I., Von Herbay, A., et al. (2000) Protective role of neurotrophins in experimental inflammation of the rat gut. Gastroenterology 119, 368–376.
Kitani, A., Fuss, I. J., Nakamura, K., Schwartz, O. M., Usui, T., and Strober, W. (2000) Treatment of experimental (Trinitrobenzene sulfonic acid) colitis by intranasal administration of transforming growth factor (TGF)-beta1 plasmid: TGF-beta1-mediated suppression of T helper cell type 1 response occurs by interleukin (IL)-10 induction and IL-12 receptor beta2 chain downregulation. J. Exp. Med. 192, 41–52.
Zeeh, J. M., Zorlu Riley, N. E., Hoffmann, P., Ruwe, M., Goebell, H., Gerken, G., et al. (2001) Mycophenolate mofetil reduces tissue damage and inflammation in an experimental model of colitis in rats. Scand. J. Gastroenterol. 36, 66–70.
Armstrong, A. M., Foulkes, R., Jennings, G., Gannon, C., Kirk, S. J., and Gardiner, K. R. (2001) Tumour necrosis factor inhibitors reduce the acute-phase response in hapten-induced colitis. Br. J. Surg. 88, 235–240.
Nakase, H., Okazaki, K., Tabata, Y., Uose, S., Ohana, M., Uchida, K., et al. (2001) An oral drug delivery system targeting immune-regulating cells ameliorates mucosal injury in trinitrobenzene sulfonic acid-induced colitis. J. Pharmacol. Exp. Ther. 297, 1122–1118.
Guo, X., Ko, J. K., Mei, Q. B., and Cho, C. H. (2001) Aggravating effect of cigarette smoke exposure on experimental colitis is associated with leukotriene B4 and reactive oxygen metabolites. Digestion 63, 180–187.
Yoshida, N., Yoshikawa, T., Yamaguchi, T., Naito, Y., Tanigawa, T., Murase, H., et al. (2001) A novel water-soluble vitamin E derivative protects against experimental colitis in rats. Antioxid. Redox Signal. 1, 555–562.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Humana Press Inc.
About this protocol
Cite this protocol
Whittle, B.J.R., Cavicchi, M., Lamarque, D. (2003). Assessment of Anticolitic Drugs in the Trinitrobenzene Sulfonic Acid (TNBS) Rat Model of Inflammatory Bowel Disease. In: Winyard, P.G., Willoughby, D.A. (eds) Inflammation Protocols. Methods in Molecular Biology, vol 225. Humana Press. https://doi.org/10.1385/1-59259-374-7:209
Download citation
DOI: https://doi.org/10.1385/1-59259-374-7:209
Publisher Name: Humana Press
Print ISBN: 978-0-89603-970-4
Online ISBN: 978-1-59259-374-3
eBook Packages: Springer Protocols